Enzyme- and Chemo-enzyme-Catalyzed Stereodivergent Synthesis

Jiajing Lv, Ya-Qi Ding, Chenglong Huang, Lingling Guo, J. Fang, Xian Jia, Wenhe Zhang, Song You, Bin Qin
{"title":"Enzyme- and Chemo-enzyme-Catalyzed Stereodivergent Synthesis","authors":"Jiajing Lv, Ya-Qi Ding, Chenglong Huang, Lingling Guo, J. Fang, Xian Jia, Wenhe Zhang, Song You, Bin Qin","doi":"10.1055/s-0042-1755556","DOIUrl":null,"url":null,"abstract":"Multiple stereoisomers can be found when a substance contains chiral carbons in its chemical structure. To obtain the desired stereoisomers, asymmetric synthesis was proposed in the 1970s and developed rapidly at the beginning of this century. Stereodivergent synthesis, an extension of asymmetric synthesis in organic synthesis with the hope to produce all stereoisomers of chiral substances in high conversion and selectivity, enriches the variety of available products and serves as a reference suggestion for the synthesis of their derivatives and other compounds. Since biocatalysis has outstanding advantages of economy, environmental friendliness, high efficiency, and reaction at mild conditions, the biocatalytic reaction is regarded as an efficient strategy to perform stereodivergent synthesis. Thus, in this review, we summarize the stereodivergent synthesis catalyzed by enzymes or chemo-enzymes in cases where a compound contains two or three chiral carbons, i.e., at most four or eight stereoisomers are present. The types of reactions, including reduction of substituent ketones, cyclization reactions, olefin addition, and nonredox transesterification reactions, are also discussed for the understanding of the progress and application of biocatalysis in stereodivergent synthesis.","PeriodicalId":19767,"journal":{"name":"Pharmaceutical Fronts","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Fronts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1755556","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Multiple stereoisomers can be found when a substance contains chiral carbons in its chemical structure. To obtain the desired stereoisomers, asymmetric synthesis was proposed in the 1970s and developed rapidly at the beginning of this century. Stereodivergent synthesis, an extension of asymmetric synthesis in organic synthesis with the hope to produce all stereoisomers of chiral substances in high conversion and selectivity, enriches the variety of available products and serves as a reference suggestion for the synthesis of their derivatives and other compounds. Since biocatalysis has outstanding advantages of economy, environmental friendliness, high efficiency, and reaction at mild conditions, the biocatalytic reaction is regarded as an efficient strategy to perform stereodivergent synthesis. Thus, in this review, we summarize the stereodivergent synthesis catalyzed by enzymes or chemo-enzymes in cases where a compound contains two or three chiral carbons, i.e., at most four or eight stereoisomers are present. The types of reactions, including reduction of substituent ketones, cyclization reactions, olefin addition, and nonredox transesterification reactions, are also discussed for the understanding of the progress and application of biocatalysis in stereodivergent synthesis.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
酶和化学酶催化的立体发散合成
当一种物质的化学结构中含有手性碳时,就会形成多个立体异构体。为了获得所需的立体异构体,20世纪70年代提出了不对称合成方法,并在本世纪初得到了迅速发展。立体发散合成是不对称合成在有机合成中的延伸,其目的是制备手性物质的所有立体异构体,具有较高的转化率和选择性,丰富了可用产物的种类,为其衍生物和其他化合物的合成提供了参考建议。由于生物催化具有经济、环保、高效、反应条件温和等突出的优点,生物催化反应被认为是进行立体发散合成的有效方法。因此,本文综述了由酶或化学酶催化的含有两个或三个手性碳的化合物,即最多存在四个或八个立体异构体的立体发散合成。讨论了取代基酮还原反应、环化反应、烯烃加成反应和非氧化还原酯交换反应等反应类型,以了解生物催化在立体分散合成中的进展和应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
24
审稿时长
15 weeks
期刊最新文献
Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors Discovery of a Novel Benzimidazole Necroptosis Inhibitor from an In-House Compound Library Research Strategies for Precise Manipulation of Micro/Nanoparticle Drug Delivery Systems Using Microfluidic Technology: A Review Advances in Tumor Targeting Biomimetic Drug Delivery Systems: A Promising Approach for Antitumor Therapy 3D Printing Pharmaceuticals: Current Status and Future Opportunities
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1